BO
GILD icon

BRR OpCo’s Gilead Sciences GILD Stock Holding History

BRR OpCo’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-18,064
Closed -$1.14M – 185
2020
Q3 		$1.14M Buy
18,064
+1,560
+9% +$108K 0.19% 71
2020
Q2 		$1.27M Sell
16,504
-576
-3% -$44.1K 0.22% 56
2020
Q1 		$1.28M Sell
17,080
-546
-3% -$37.7K 0.24% 43
2019
Q4 		$1.15M Buy
17,626
+2,015
+13% +$131K 0.16% 61
2019
Q3 		$989K Buy
15,611
+1,250
+9% +$81.7K 0.16% 58
2019
Q2 		$970K Buy
14,361
+10,988
+326% +$723K 0.16% 61
2019
Q1 		$219K Buy
+3,373
New +$224K 0.04% 148
2014
Q3 		– Sell
-4,031
Closed -$334K – 110
2014
Q2 		$334K Buy
4,031
+645
+19% +$50.2K 0.14% 77
2014
Q1 		$240K Sell
3,386
-4
-0.1% -$314 0.1% 85
2013
Q4 		$255K Buy
+3,390
New +$236K 0.11% 85

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BRR OpCo's GILD Position: Q4 2020 in Review

BRR OpCo sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 18,064 shares — an estimated $1.14M sold.

BRR OpCo first reported a position in GILD in Q4 2013 and held it in 10 quarters. The position peaked at $1.28M in Q1 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q4 2020.

  • BRR OpCo reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
  • BRR OpCo sold 18,064 Gilead Sciences shares in Q4 2020, an estimated $1.14M.
  • BRR OpCo first reported a position in Gilead Sciences in Q4 2013 and held it in 10 quarters.
  • BRR OpCo's Gilead Sciences position peaked at $1.28M in Q1 2020.
  • 1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.

Based on BRR OpCo's 13F filing for Q4 2020, filed 10 Feb 2021.